Vir Biotechnology, Inc. today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors at its upcoming annual meeting of stockholders on May 29, 2024.
The trial for a Tulsa man who previously resided in Woodward began on Monday morning with voir dire (jury selection) and opening statements from counsel in the case.
MIT alumnus Albert E. Almada studies super-healing species to explore regeneration, and how those processes may go awry in degenerative muscle diseases and aging.